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Two independent techniques, in situ hybridization on frozen sections and reassociation kinetics, have been
used to localize Epstein-Barr virus genomes in tissue samples from healthy human adults. Whereas specimens
taken from the palatine tonsils were invariably negative, all samples from the parotid gland were positive when
tested with either technique. This observation suggests that the parotid gland is, besides the peripheral
lymphocytes, a site of lifelong persistence of Epstein-Barr virus and probably the site of low-level virus
production which may be the source of virus found in the oropharynx.
Epstein-Barr virus (EBV) causes infectious mononucleo-
sis as a primary disease, persists lifelong in peripheral B
lymphocytes (7), and seems to be an essential factor in the
development of nasopharyngeal carcinoma and the African
Burkitt's lymphoma (for a review, see references 4 and 11).
Nevertheless, it is not known where this virus is produced
during acute or persistent infections, and the site of its
persistence has not been identified. Virus can be regularly
detected in saliva of infectious mononucleosis patients (5)
and seropositive healthy persons (6). The site of virus
production could be B lymphocytes of the oropharynx,
because only these cells are known to have EBV receptors.
Alternatively, specialized cells at specific sites might pro-
vide the suitable conditions for the persistence and low-level
production of EBV, resembling a situation found with Mar-
ek's disease virus (3).
We looked for evidence of persistence of EBV in tissues of
two origins: tonsils of the palate, which represent lympho-
cyte-rich organs in the oropharynx, and parotid glands,
which are the major salivary glands and are known to be the
site of replication for other viruses exemplified by mumps
virus (12) and cytomegalovirus (10). Because one cannot
assume that virus production will be frequent in a given
specimen of a healthy individual, all techniques for detecting
only late viral products or even virus particles seemed to be
inappropriate, and we decided to use in situ hybridization to
detect viral nucleic acid sequences in human tissues. This
technique was used with materials from human tumors in an
attempt to localize EBV genomes ih the epithelial tumor
cells of nasopharyngeal carcinomas (14).
MATERIALS AND METHODS
Biopsy materials. All tissue donors were adults ranging
from 25 to 45 years of age without clinical or serological
evidence for acute EBV infection. The antibody titers to
EBV capsid antigen ranged between 1:32 and 1:126, no
antibody titers to EBV early antigen could be detected, and
antibodies to EBV nuclear antigen were present. Parotid
glands from three persons (victims of traffic accidents and
patients who had undergone operations for unrelated rea-
sons) were used for in situ hybridization tests (see Fig. 1).
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3H-labeled EBV DNA. 3H-labeled EBV DNA was prepared
from EBV virion DNA, which was rebanded on CsCI (15),
used for nick translation, and has been described elsewhere
(9).
3H-labeled herpes simplex type 1 DNA. H-labeled herpes
simplex virus type 1 DNA was purified from virions of the F
strain, rebanded in CsCl, labeled as described for EBV
DNA, and used in all experiments as control in consecutive
sections.
In situ hybridization. The method used was based on
procedures described before (2, 14, 15) with modifications.
Briefly, 8-pm-thick frozen sections were spread on pretreat-
ed slides (2), fixed 20 min in 25% acetic acid-75% methanol,
incubated 30 min at 700C in 2x SSC (0.3 M NaCI, 0.03 M
sodium citrate), and treated 15 min at 37°C with 1 pLg of
proteinase K per ml. Immediately preceding hybridization,
the preparations were denaturated by immersion into 0.1x
SSC for 30 s at 98°C and transferred to the same buffer at
0°C. A 10-,ul portion of hybridization solution containing
100,000 cpm of denatured 3H-labeled EBV DNA (specific
activity, 5 x 106 cpm/p.g in 50% formamide, 0.6 M NaCI, 10
mM Tris-hydrochloride [pH 7.5], 1 mM EDTA, 100 p.1 of
polyadenylate, 0.02% [wt/vol] polyvinylpyrrolidone, 0.02%
Ficoll, and 1 mg each of bovine serum albumin and tRNA
per ml) was placed under siliconized cover slips and sealed
with rubber cement. After hybridization at 45°C for 48 h, the
cover slips were removed, and the slides were washed with 5
changes of formamide buffer (as above, without polyanions)
altogether for 15 h, rinsed with 2x SSC, rinsed for 5 min in
70% ethanol-300 mM ammonium acetate and 5 min in 90%
ethanol-300 mM ammonium acetate, and air dried. The
preparations were dipped in Kodak NTB emulsion diluted
1:1 with 600 mM ammonium acetate at 40°C, dried, and
exposed for 3 weeks at 4°C. After development with Kodak
D-19 X-ray developer, the preparations were stained with
Giemsa stain.
Reassociation kinetics. The DNA mixtures were denatured
and fragmented by treatment with 0.27 N NaOH for 10 min
at 100°C and subsequently neutralized with HCI. The end
concentration in the hybridization reaction was 0.5 M NaCI-
0.2 M Tris-hydrochloride-10 mM EDTA-0.05% Sarkosyl
(pH 8.0), and the temperature was 68°C. Double-stranded
DNA was separated from single-stranded DNA by hydroxy-
lapatite chromatography at 60°C. Single strands were eluted
with 0.14 M and double strands with 0.4 M phosphate buffer,
and the whole fractions were counted.
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RESULTS
Frozen sections from five tonsils and three parotid glands
were hybridized with a probe of nick-translated 3H-labeled
EBV DNA. As controls, we used cell lines containing no
EBV genomes (BJA-B) (not shown) and P3HR1 cultures
with few genomes per cell but containing virus-producing
cells having a heavy genome load. BJA cells were essentially
free of grains (similar to Fig. 1B and H). P3HR1 cells (Fig.
1A) contained several cells heavily labeled with grains
representing virus-producing cells, whereas the other cells
were devoid of grains. As additional controls, consecutive
sections of all samples tested were hybridized with 3H-
labeled herpes simplex viral DNA of comparable specific
activity. Careful analysis of these preparations did not reveal
any significant hybridization signals. One area demonstrat-
ing the average background is shown in Fig. 113. The frozen
sections from parotid gland biopsies (Fig. 1B through G)
obtained from different individuals contained variable num-
bers of cells containing variable numbers of grains. Very few
cells contained as heavy a load of grains as that seen in the
virus-producing cells of the P3HR1 line (Fig. 1A). In some
instances, the distribution of these grains was restricted to
the outer areas of the nucleus (Fig. 1F) and was similar to the
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FIG. 1. Autoradiograms after in situ hybridization are shown for the following materials: A, cell smear from P3HR1 cells; B through G,
frozen sections from parotid glands; and H, frozen section from a tonsil. Preparation B was hybridized with 3H-labeled DNA from herpes
simplex virus; for all other preparations, 3H-labeled EBV DNA was used.
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distribution of total chromatin in herpes-infected cells. The
fact that virus genome-containing cells were rather loosely
scattered did not permit the use of consecutive sections for
an identification of the cell types. Because cytoplasmic
staining methods did not work after the in situ hybridization
procedure, the question remains unanswered for the cell
types carrying the EBV genome. However, the analysis of a
series of sections (Fig. IC throughG) suggests that the EBV
genome-carrying cells are not infiltrating lymphocytes. The
most typical location of cells with grains representing EBV
DNA was within the lumen of duct-like structures, and
usually a good contrast to the background grains present in
adjacent cells was evident (Fig.1C throughG).
Further up in the duct (Fig.1E), the EBV genome-
containing cells seem to be in the lining epithelium of the
duct, suggesting that during the lytic cycle of virus produc-
tion these cells may lose their contact with neighboring cells
and appear in the lumen of more distal sections (Fig.1C and
D). In contrast, similar sections from tonsils were essentially
free of grains and therefore do not contain detectable num-
bers of EBV genome-containing or EBV-producing cells
(Fig. 1H).
Due to inherent problems in the technique of in situ
hybridization, in which partial evaporation of solvent or
nonspecific binding of the radioactive probe DNA might in
some experiments mimic positive hybridization, it seemed
desirable that these results be confirmed with an indepen-
dent technique which allows the application of stringent
conditions of hybridization. This was done by using DNA
extracted from six tonsils and three parotid glands and
hybridized in liquid with nick-translated EBV virion DNA.
Figure 2 shows the kinetics of the reassociation reaction.
DNA from one parotid gland contained almost as much viral
DNA as a DNA preparation from Raji cells, which was
mixed with a 10-fold excess of calf thymus DNA and thus
was representative ofa DNA containing about six viral
genomes per cell. The other DNA preparations from parotid
glands contained approximately one-tenth that amount of
viral DNA and hybridized similarly to Raji DNA mixed with
a 100-fold excess of calf thymus DNA. The reassociation
kinetics from the tonsils were indistinguishable from those of
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FIG. 2. Reassociation kinetics with DNA from EBV (5 x 10'
cpm/,ug) as tracer, DNA from calf thymus (3. negative control) as
driver, and Raji cells with a 10-fold (1) and 100-fold (2) excess of calf
thymus DNA as positive contrqls. Test DNA was obtained from
tonsils (7, 8) and parotid glands (4, 5, 6).
pure calf thymus DNA and, therefore (within the limits of
the test used), excluded the presence of EBV DNA in DNA
extracted from tonsils.
DISCUSSION
Under the conditions used, the sensitivity of the in situ
hybridization did not detect single copies or small groups of
copies of EBV DNA within a cell. It may be that more cells
within the sections shown in Fig. 1 contain EBV DNA. Only
the producer cells of the P3HR1 line are clearly labeled.
whereas the other cells which also have few EBV genomes
are negative (Fig. 1A). The positive cells from biopsy
materials might be a subset of EBV genome-carrying cells
with a higher genome load.
Because all tissues were taken from normal adults without
acute EBV infection, our data suggest that the parotid gland
is an organ in which EBV is produced and released into the
saliva. The isolation of EBV from the efferent duct of the
salivary gland (8) supports this hypothesis. Conversely, the
direct evidence of EBV DNA-containing cells adds confi-
dence to the assumption that the virus isolated was indeed
produced in the salivary gland and did not ascend through
the duct. The fact that antibodies to major proteins synthe-
sized during virus replication (1) which are serologically
defined as the EA complex are usually absent in immune
patients, despite an evident virus production. might find its
explanation in the localization of the virus-producing cells.
Early antigens may be shed together with virus upon lysis of
the producer cells with the saliva and may therefore not be
available as an antigen within the body. Thelifelong anti-
body titers to virus capsid antigen might be maintained
because virus from the saliva is absorbed by receptor-
bearing cells or macrophages of the oropharynx and continu-
ously presented as antigen to the immune system of the body(13). Virus shed from the parotid gland may also constantly
convert new B lymphocytes to contain EB nuclear antigen
and EBV DNA.
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